19 August 2013
Peripheral corneal ulceration associated with rheumatoid arthritis
Vasileios Karampatakis, Vasileios Konidaris, Maria Michailidou, Antonios Gerofotis, Michail DaniilidisDOI: 10.12659/AJCR.883998
Am J Case Rep 2013; 14:318-321
Abstract
Background: To report a case of a patient with rheumatoid arthritis (RA) and associated peripheral corneal ulceration.
Case Report: A 60-year-old woman with RA diagnosed 15 years ago, under immunosuppressive therapy (IV abatacept 250 mg/month), demonstrated blurring of vision in her RE (right eye). Visual acuity was 6/10 in the RE and 10/10 in the LE. Slit lamp examination revealed a paracentral superior corneal melt in the RE. Anterior chamber reaction was 2+. Laboratory investigations revealed positive anti-Ro and anti-La, anti-Extractable Nuclear Antigens (anti-ENA, ELISA), while anti-Sm, anti-Rnp, anti-Jo1 and anti-Scl70 were found negative. IgG and IgA serum immunoglobulins were found elevated, but IgE and IgM were within normal levels. Further evaluation for the underlying disease revealed highly elevated rheumatoid factor and C-reactive protein. The patient, who had been receiving anti-TNF during the last 6 months, underwent treatment with topical tobramycin and lubricants and oral prednisone 60 mg/day with tapering doses, to which methotrexate p.os. 15 mg/week was added.
The condition improved within a few days after the initiation of prednisone treatment. Re-epithelization occurred 1 week after the onset of the immunosuppressive treatment. Only punctate fluorescein dye uptake was detected in the margins of the lesion.
Conclusions: The effective control of the underlying disease and early diagnosis of the dry eye syndrome in RA patients may prevent serious corneal complications such as corneal ulceration. The initiation of treatment with steroids and immunosuppresants was found to halt the progression of keratolysis, and assisted re-epithelization.
Keywords: Keratolysis, rheumatoid arthritis, peripheral ulceration, immunosuppressive therapy, ant-TNF, anti-ENA
886 6
In Press
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940611
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939870
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940681
31 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941006
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250